Home  |  Select Your State  |  New Hampshire

In 2026, CCPA commissioned a study among 150 registered voters in New Hampshire. Across party lines, voters overwhelmingly view obesity as a serious chronic disease that deserves medical treatment, strongly support efforts to help eligible patients access FDA-approved obesity medicines, and believe Medicaid should play a role in providing coverage. Specific findings include:

Obesity is a Major Public Health Concern

  • Nearly three-quarters of New Hampshire voters (77%) see obesity as a serious problem in their state, with roughly one-third saying it is a very serious issue, and close to three-quarters (73%) reporting a personal connection to obesity.
  • More than four-in-five New Hampshire voters (84%) agree obesity deserves the same coverage as other chronic diseases, with more than two-in-five strongly agreeing (45%).

Voters Want Patients to Have Access to Treatment

  • Most voters agree all residents, regardless of income or socioeconomic status, should have equal access to obesity medicines (85%) and believe doctors should drive decision-making (88%).
  • Four-in-five New Hampshire voters (78%) are deeply concerned that some patients are unable to access FDA-approved obesity treatments their doctors recommend because their state Medicaid program does not cover them.
  • Three-in-five New Hampshire voters (61%) view obesity as a chronic disease that should be treated with obesity medicines – not simply a matter of personal and lifestyle changes (39%).
  • New Hampshire voters reject cost-based arguments against coverage. Nearly two-thirds (63%) believe Medicaid coverage for obesity medicines is an investment in long-term health that prevents costly complications and reduces healthcare costs, rather than viewing medicines as too expensive for Medicaid to cover (23%).
  • Underscoring the importance of access, three-quarters of voters in New Hampshire (75%) recognize the importance of obesity treatment for communities that face higher rates of chronic diseases and agree that Medicaid coverage of obesity medicines would help improve lives and lead to better health outcomes (79%).

Medicaid Has a Responsibility to Help Provide Access

  • Most New Hampshire voters (77%) think it is important for policymakers to restore access to obesity medicines in their state.
  • Most New Hampshire voters also support policies that would broaden access for low-income patients – including establishing a program in their state (82%) or expanding Medicaid eligibility (81%) – to ensure they have access to obesity medications.
  • The majority of New Hampshire voters (77%) support their state’s Medicaid program restoring FDA-approved obesity treatments for eligible patients.
    • Support for state Medicaid coverage of obesity treatments is strong across party, with majorities of Democrats* (71%), Independents* (69%), and Republicans* (89%) in New Hampshire backing this coverage.

New Hampshire Voters Reward Policymakers Who Support Medicaid Coverage of Obesity Medicines

  • 77% of New Hampshire voters say they are more likely to support legislators who back Medicaid restoring obesity medicine coverage, versus just 12% who say less likely.
    • Democrats* (72%), Independents* (68%), and Republicans* (88%) in New Hampshire are more likely to support lawmakers who back Medicaid coverage of FDA-approved obesity medications.

 


 

DOWNLOAD OBESITY’S IMPACT ON NEW HAMPSHIRE INFOGRAPHIC

Click on an image below to enlarge

 

 


 

DOWNLOAD STATE OF CHRONIC DISEASE INFOGRAPHIC

Click on an image below to enlarge